TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau

  1. Maxime WC Rousseaux
  2. Maria de Haro
  3. Cristian A Lasagna-Reeves
  4. Antonia De Maio
  5. Jeehye Park
  6. Paymaan Jafar-Nejad
  7. Ismael Al-Ramahi
  8. Ajay Sharma
  9. Lauren See
  10. Nan Lu
  11. Luis Vilanova-Velez
  12. Tiemo J Klisch
  13. Thomas F Westbrook
  14. Juan C Troncoso
  15. Juan Botas
  16. Huda Y Zoghbi  Is a corresponding author
  1. Baylor College of Medicine, United States
  2. Texas Children's Hospital, United States
  3. The University of Toronto, Canada
  4. Ionis Pharmaceuticals, United States
  5. Johns Hopkins University School of Medicine, United States

Abstract

Several neurodegenerative diseases are driven by the toxic gain-of-function of specific proteins within the brain. Elevated levels of alpha-synuclein (α-Syn) appear to drive neurotoxicity in Parkinson's disease (PD); neuronal accumulation of tau is a hallmark of Alzheimer's disease (AD); and their increased levels cause neurodegeneration in humans and model organisms. Despite the clinical differences between AD and PD, several lines of evidence suggest that α-Syn and tau overlap pathologically. The connections between α-Syn and tau led us to ask whether these proteins might be regulated through a shared pathway. We therefore screened for genes that affect post-translational levels of α-Syn and tau. We found that TRIM28 regulates α-Syn and tau levels and that its reduction rescues toxicity in animal models of tau- and α-Syn-mediated degeneration. TRIM28 stabilizes and promotes the nuclear accumulation and toxicity of both proteins. Intersecting screens across comorbid proteinopathies thus reveal shared mechanisms and therapeutic entry points.

Article and author information

Author details

  1. Maxime WC Rousseaux

    Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States
    Competing interests
    No competing interests declared.
  2. Maria de Haro

    Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States
    Competing interests
    No competing interests declared.
  3. Cristian A Lasagna-Reeves

    Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States
    Competing interests
    No competing interests declared.
  4. Antonia De Maio

    Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, United States
    Competing interests
    No competing interests declared.
  5. Jeehye Park

    Program in Genetics and Genome Biology, The Hospital for Sick Children, The University of Toronto, Toronto, Canada
    Competing interests
    No competing interests declared.
  6. Paymaan Jafar-Nejad

    Ionis Pharmaceuticals, Carlsbad, United States
    Competing interests
    No competing interests declared.
  7. Ismael Al-Ramahi

    Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States
    Competing interests
    No competing interests declared.
  8. Ajay Sharma

    Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States
    Competing interests
    No competing interests declared.
  9. Lauren See

    Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States
    Competing interests
    No competing interests declared.
  10. Nan Lu

    Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States
    Competing interests
    No competing interests declared.
  11. Luis Vilanova-Velez

    Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States
    Competing interests
    No competing interests declared.
  12. Tiemo J Klisch

    Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States
    Competing interests
    No competing interests declared.
  13. Thomas F Westbrook

    Department of Molecular and Human Genetics, Baylor College of Medicine, Boston, United States
    Competing interests
    No competing interests declared.
  14. Juan C Troncoso

    Division of Neuropathology, Johns Hopkins University School of Medicine, Baltimore, United States
    Competing interests
    No competing interests declared.
  15. Juan Botas

    Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States
    Competing interests
    No competing interests declared.
  16. Huda Y Zoghbi

    Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States
    For correspondence
    hzoghbi@bcm.edu
    Competing interests
    Huda Y Zoghbi, Senior editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0700-3349

Funding

Howard Hughes Medical Institute

  • Huda Y Zoghbi

Michael J. Fox Foundation for Parkinson's Research (Target Validation Program 2014)

  • Huda Y Zoghbi

Canadian Institutes of Health Research (201210MFE-290072-173743)

  • Maxime WC Rousseaux

National Institutes of Health (1K22NS092688-01)

  • Cristian A Lasagna-Reeves

National Institutes of Health (U54 HD083092)

  • Huda Y Zoghbi

National Institutes of Health (P50 NS38377)

  • Juan C Troncoso

National Institutes of Health (P50 AG05146)

  • Juan C Troncoso

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Up to five mice were housed per cage and kept on a 12 h light; 12 h dark cycle and were given water and standard rodent chow ad libitum. All procedures carried out in mice were approved by the Institutional Animal Care and Use Committee for Baylor College of Medicine and Affiliates.

Human subjects: Tissue from patients with PD, AD, PSP and control subjects were obtained from the Neuropathology Core at the Johns Hopkins Udall Centre. Tissue was obtained from consenting donors and use conformed to JHMI Institutional Review Board approved protocols.

Copyright

© 2016, Rousseaux et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 7,428
    views
  • 100
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Maxime WC Rousseaux
  2. Maria de Haro
  3. Cristian A Lasagna-Reeves
  4. Antonia De Maio
  5. Jeehye Park
  6. Paymaan Jafar-Nejad
  7. Ismael Al-Ramahi
  8. Ajay Sharma
  9. Lauren See
  10. Nan Lu
  11. Luis Vilanova-Velez
  12. Tiemo J Klisch
  13. Thomas F Westbrook
  14. Juan C Troncoso
  15. Juan Botas
  16. Huda Y Zoghbi
(2016)
TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau
eLife 5:e19809.
https://doi.org/10.7554/eLife.19809

Share this article

https://doi.org/10.7554/eLife.19809

Further reading

    1. Developmental Biology
    2. Neuroscience
    Ev L Nichols, Joo Lee, Kang Shen
    Research Article

    During development axons undergo long-distance migrations as instructed by guidance molecules and their receptors, such as UNC-6/Netrin and UNC-40/DCC. Guidance cues act through long-range diffusive gradients (chemotaxis) or local adhesion (haptotaxis). However, how these discrete modes of action guide axons in vivo is poorly understood. Using time-lapse imaging of axon guidance in C. elegans, we demonstrate that UNC-6 and UNC-40 are required for local adhesion to an intermediate target and subsequent directional growth. Exogenous membrane-tethered UNC-6 is sufficient to mediate adhesion but not directional growth, demonstrating the separability of haptotaxis and chemotaxis. This conclusion is further supported by the endogenous UNC-6 distribution along the axon’s route. The intermediate and final targets are enriched in UNC-6 and separated by a ventrodorsal UNC-6 gradient. Continuous growth through the gradient requires UNC-40, which recruits UNC-6 to the growth cone tip. Overall, these data suggest that UNC-6 stimulates stepwise haptotaxis and chemotaxis in vivo.

    1. Neuroscience
    Sainan Liu, Jiepin Huang ... Yan Yang
    Research Article

    Social relationships guide individual behavior and ultimately shape the fabric of society. Primates exhibit particularly complex, differentiated, and multidimensional social relationships, which form interwoven social networks, reflecting both individual social tendencies and specific dyadic interactions. How the patterns of behavior that underlie these social relationships emerge from moment-to-moment patterns of social information processing remains unclear. Here, we assess social relationships among a group of four monkeys, focusing on aggression, grooming, and proximity. We show that individual differences in social attention vary with individual differences in patterns of general social tendencies and patterns of individual engagement with specific partners. Oxytocin administration altered social attention and its relationship to both social tendencies and dyadic relationships, particularly grooming and aggression. Our findings link the dynamics of visual information sampling to the dynamics of primate social networks.